The College of Medical Sciences received 2,000 doses of the Taiwanese vaccine for phase 3 studies

San Lorenzo. “On the night of Friday, August 27, 2,000 doses of Taiwan’s MVC COVID-19 vaccine arrived in Asuncion to begin a Phase 3 study with Asuncion National University College of Medical Sciences (FCMUNA),” they revealed from the aforementioned institution.

They explained that this vaccine was developed by the Taiwanese laboratory Medigen Vaccine Biologics Corporation, in cooperation with the National Institutes of Health in the United States (National Institutes of Health, NIH in English), using a traditional platform, with a protein subunit that is also used in other vaccines such as the hepatitis vaccine. liver B.

They added: “In Paraguay, it is preparing to start its third phase study soon, at the Employment Centers of Hospital de Clínicas de la Vcomona, in the city of San Lorenzo, and of the Tesãi del Alto Paraná Foundation.”

They also noted that the whole process has the support of the health authority of the Ministry of Public Health and Social Care (MSPyBS), through the General Directorate of Health Surveillance, the National Directorate of Health Surveillance (DINAVISA), and the Central Public Health Laboratory (LCSP). ) and the Expanded Program on Immunization (PAI).

In particular, they noted, “This is the first time that Paraguay has joined the process of developing a new vaccine against COVID-19.”

In addition, as technical information about Taiwanese biology, they stressed that during the phase II studies of the Medigen vaccine, the seroconversion rate was 99.8% and this means that almost all people who will receive the vaccine will generate antibodies to the COVID-19 virus.”

They also noted that on July 19 this year, the Taiwan Ministry of Health approved the emergency use (USA) of the Medigen vaccine, and that since August 23 it has started immunizing the Taiwanese population with this vaccine.

As a sign of confidence in the biology, the first to receive the injection was the President of the Republic of China (Taiwan), Tsai Ing-wen. It’s Over So far, there are more than 300,000 people who have received their first dose of Medigen in Taiwan.

comments

comments